INTRODUCTION
A hepatic inflammatory p s e u d o t u m o r ( I P T ) i s histologically characterized by proliferating fibrous tissue and inflammatory cells, and is generally considered to be benign in its biological behavior [1] [2] [3] [4] [5] [6] . However, it can clinically masquerade as a malignant growth such as a hepatocellular carcinoma or a metastatic tumor [2] [3] [4] . In some cases, an aggressive course of hepatic IPT has been reported [2, 5] . The malignant transformation of hepatic IPT is extremely rare [7, 8] and, to our knowledge, there has only been one case published of primary hepatic lymphoma arising from a hepatic IPT [7] . Tumor-forming pancreatitis has been called an inflammatory pancreatic mass [9] or pseudotumoral pancreatitis [10] , and mostly involves the pancreas head with obstructive jaundice [9] . Most recently, a variant of tumor-forming pancreatitis named follicular pancreatitis has been described [11] [12] [13] , histologically differing from autoimmune pancreatitis [11] .
Here, we report a rare case of a hepatic diffuse large B-cell lymphoma (DLBCL) complicated with a hepatic IPT in a patient with tumor-forming, lymphoplasmacytic pancreatitis.
CASE PRESENTATION
A 73-year-old Japanese man was referred to our hospital because of obstructive jaundice. He had undergone a cholecystectomy at 62 years of age. A solitary low-density mass was present in the pancreas head as revealed by computed (Figs. 6C, D) . In consideration of these findings, the hepatic tumor was finally diagnosed as a DLBCL complicated with an IPT. The tumor decreased in size and disappeared after six cycles of treatment with the monoclonal antibody rituximab plus a cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) regimen. During the 12-month follow-up after R-CHOP therapy, no recurrence was observed and the patient's condition was good at the most recent visit.
Immunohistochemical analysis of CD138, IgG, and IgG4 was performed. Results from histological analysis, immunohistochemistries, and in situ hybridization for EpsteinBarr virus-encoded small RNA (EBER)-1 are summarized in Table I . IgG4-positive cells were increased in the bile duct and periportal lymph node, but not in the other tissues. tomography (CT) (Fig. 1) . These imaging observations led to a diagnosis of a pancreas head cancer. A choledochojejunostomy was performed because intraoperative frozen sections showed atrophic parenchyma, fibrosis, and lymphoid follicle formation, but no malignant cells. During surgery, biopsy samples were excised from the thickened common bile duct and periportal lymph nodes. Subepithelial fibrosis and an infiltration of lymphoplasma cells were detected in the bile duct wall, and lymph follicle hyperplasia with an increase in plasma cells was observed in the lymph nodes.
After a choledochojejunostomy, the pancreas head mass gradually decreased in size and finally disappeared. The patient suffered an intermittent high fever which was successfully treated with antibiotics. At 46 months after surgery, a circular, low-density tumor was found in the left hepatic lobe (Fig. 2A) . The tumor gradually shrank, and finally formed a scar without therapy (Fig. 2B) . Recurrence occurred as a hypovascular tumor in the right lobe 76 months after surgery, but also disappeared without therapy. Subsequently, a well-demarcated tumor was observed along the intrahepatic bile ducts of the right anterior segment 81 months after surgery (Fig. 2C ). At this time, soluble interleukin-2 receptor (sIL-2R) was 523 U/ ml. A liver biopsy was performed for the first time, which demonstrated a severe lymphoplasma cell infiltration (Fig. 3 ). CD20-positive B-cells and CD3-positive T-cells were detected by immunohistochemistry, supporting a diagnosis of hepatic IPT. Ninety-five months after surgery, the patient had an intermittent high fever, and the hepatic tumor had expanded. Histologically, a second biopsy of the tumor also revealed an IPT. Flow cytometry of the tumor following CD45 gating for lymphocytes detected 80% CD3/CD5/CD7-positive cells (T-cell lineage) and 20% CD19/CD20-positive cells (B-cell lineage), with the B-cell population showing almost equal expression of kappa and lambda immunoglobulin light chains. Subsequently, an excisional biopsy of the mesenteric lymph node was performed, and the histology was considered to be benign (sIL-2R, 928 U/l).
The patient had a persistently high fever, and the hepatic tumor had increased to 10 cm in size 102 months after surgery (Fig. 4) . On abdominal ultrasound examination, two biopsy specimens (3rd) were taken from different regions of the hepatic tumor. One specimen obtained from the boundary of the tumor showed an IPT ( Fig. 5A ) with CD20-positive B-cells and CD3-positive T-cells (Figs. 5B, C) . The other specimen obtained from the interior of the tumor had a diffuse 
DISCUSSION
In this case, tumor-forming pancreatitis was initially observed, with its subsequent development into a recurrent hepatic IPT, followed by a hepatic DLBCL.
On CT imaging, a hepatic IPT appeared as a low-density mass [4] [5] [6] . The area of low attenuation in this lesion reflects the presence of chronic inflammatory changes, including histiocytes and lymphoplasmacytes, while areas of iso-or high attenuation represent fibroblastic proliferation [5] . In our case, the hepatic IPT was initially circular with low attenuation, consistent with the major histological features of lymphoplasmacytic proliferation. We subsequently observed a spontaneous regression of the hepatic ITP, similar to several reported cases [3, 6] . Lopez et al. hypothesized that a hepatic ITP is an exuberant hepatic reaction to bile stasis because the reestablishment of bile flow seems to be a definitive event in its regression. Although the etiology of an IPT remains unclear, an important mechanism is that it can develop as a complication of cholangitis [2] [3] [4] [5] [6] . In the present case, the recurrent IPT appeared as an unusual tumor formation along the intrahepatic bile ducts, probably due to the development of intrahepatic cholangitis with biliary stasis or regurgitation after a choledochojejunostomy.
There has only been one other published case of a primary hepatic lymphoma arising from a hepatic IPT [7] . In that report, the hepatic tumor remained stable for 4 years, after which a sudden enlargement of the mass signalled its malignant transformation. The first biopsy showed that the hepatic mass was diagnosed as an IPT. However, the final resected hepatic mass was composed of a DLBCL. Similar to our case, it appeared that a hepatic DLBCL arose from a hepatic IPT, suggesting that chronic inflammatory stimulation of B-cells may lead to a polyclonal origin and, later, the monoclonal expansion of these cells.
Primary hepatic lymphoma is a rare condition, making up less than 1% of all extranodal lymphomas [14, 15] . On CT imaging of a primary hepatic lymphoma, homogeneous lowattenuation masses are often detected [14] and misdiagnosed as hepatic inflammatory disease, including IPT. Our case fulfilled the definition of a primary hepatic lymphoma, that is, confined to the liver, and not found in the spleen, lymph nodes or bone marrow [16] . Surgical resection, chemotherapy, and radiotherapy are currently available as treatment modalities for primary hepatic lymphoma, but treatment is complicated by the rarity and heterogeneity of the disease [14, 15] . Chemotherapy is the recommended treatment option for extranodal DLBCL, and a R-CHOP regimen has recently become the standard therapy [17] . Our patient responded to R-CHOP chemotherapy, similar to a previous case of a primary hepatic lymphoma that was also sensitive to a R-CHOP regimen [18] . When an accurate diagnosis of a hepatic IPT is made by liver biopsy, conservative therapy is better, since few hepatic IPTs are considered to be potentially premalignant and leading to a life-threatening illness [7, 8] . Follicular pancreatitis histologically resembles autoimmune pancreatitis with prominent lymphoid follicles, but lacks storiform fibrosis, obliterative phlebitis, granulocytic epithelial lesions or prominent IgG4-positive plasma cells, and has existed as an under-recognized disease entity among the category of lymphoplasmacytic pancreatitis [11] [12] [13] .
Similarly, pancreatic localized lymphoid hyperplasia or pseudolymphoma shows lymphoid follicles composed of germinal centers surrounded by rims of lymphocytes, and lymphoplasmacytic infiltration with an increased collagenous stroma [19, 20] . In addition, Zen et al. proposed a disease entity named follicular cholangitis and pancreatitis, which showed prominent duct-centered lymphoplasmacytic infiltration and lymphoid follicles with collagenous fibrosis in a pancreatobiliary lesion [11] . In our case, we observed chronic lymphoplasmacytic pancreatitis and cholangitis with lymphoid follicle formation, but not storiform fibrosis, granulocytic epithelial lesions, obliterative phlebitis or a marked increase of IgG4-positive plasma cells, thus resembling "follicular cholangitis and pancreatitis". However, prominent ductcentered lymphoplasmacytosis could not be detected because of the small size of pancreatic samples obtained at surgery. To the best of our knowledge, there is no report of the causal relationship between mass forming pancreatitis and liver IPT except for IgG4-related disease.
In our case, IgG4-positive cells were increased in the bile duct and periportal lymph nodes, but not in other tissue samples. Storiform fibrosis or obliterative phlebitis were not present in any tissues. Further, no elevation was found in the IgG4 serum level (68.9 mg/dL). Retroperitoneal fibrosis and other manifestations of IgG4-related disease were not detected in imaging procedures and careful clinical examinations. In consideration of these findings, we excluded IgG4-related disease.
CONCLUSION
We described here a case of a hepatic lymphoma complicated with a hepatic IPT and lymphoplasmacytic (follicular) pancreatitis. This case supports the hypothesis that an IPT can transform into a malignant lymphoma. Careful observation of such cases is necessary since the development of an IPT may include the risk of a transformation to malignancy. The early detection of transformations is vital for choosing suitable and effective therapies for such cases of hepatic lymphoma.
